These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 14714396)

  • 1. Synthetic peptide-based highly immunogenic liposomal constructs.
    Frisch B; Roth A; Schuber F
    Methods Enzymol; 2003; 373():51-73. PubMed ID: 14714396
    [No Abstract]   [Full Text] [Related]  

  • 2. Oil-in-water liposomal emulsions for vaccine delivery.
    Matyas GR; Muderhwa JM; Alving CR
    Methods Enzymol; 2003; 373():34-50. PubMed ID: 14714395
    [No Abstract]   [Full Text] [Related]  

  • 3. pH-sensitive liposomes as adjuvants for peptide antigens.
    Chang JS; Choi MJ
    Methods Enzymol; 2003; 373():127-36. PubMed ID: 14714401
    [No Abstract]   [Full Text] [Related]  

  • 4. Liposomes composed of reconstituted membranes for induction of tumor-specific immunity.
    Westerman LE; Jensen PE
    Methods Enzymol; 2003; 373():118-27. PubMed ID: 14714400
    [No Abstract]   [Full Text] [Related]  

  • 5. Antibodies induced by liposomal protein exhibit dual binding to protein and lipid epitopes.
    Karasavvas N; Beck Z; Tong J; Matyas GR; Rao M; McCutchan FE; Michael NL; Alving CR
    Biochem Biophys Res Commun; 2008 Feb; 366(4):982-7. PubMed ID: 18088597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liposomal cytokines and liposomes targeted to costimulatory molecules as adjuvants for human immunodeficiency virus subunit vaccines.
    Ozpolat B; Lachman LB
    Methods Enzymol; 2003; 373():92-100. PubMed ID: 14714398
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunoliposomes for cancer therapy.
    Kontermann RE
    Curr Opin Mol Ther; 2006 Feb; 8(1):39-45. PubMed ID: 16506524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Engineering liposomes for drug delivery: progress and problems.
    Gregoriadis G
    Trends Biotechnol; 1995 Dec; 13(12):527-37. PubMed ID: 8595139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and in vivo studies of carbohydrate-based vaccines against group A streptococcus.
    Simerska P; Abdel-Aal AB; Fujita Y; Batzloff MR; Good MF; Toth I
    Biopolymers; 2008; 90(5):611-6. PubMed ID: 18381625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liposomes targeted to Fc receptors for antigen presentation by dendritic cells in vitro and in vivo.
    Serre K; Giraudo L; Leserman L; Machy P
    Methods Enzymol; 2003; 373():100-18. PubMed ID: 14714399
    [No Abstract]   [Full Text] [Related]  

  • 11. Method for the synthesis of highly pure vaccines using the lipid core peptide system.
    Moyle PM; Olive C; Good MF; Toth I
    J Pept Sci; 2006 Dec; 12(12):800-7. PubMed ID: 17131293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rational design and immunogenicity of liposome-based diepitope constructs: application to synthetic oligosaccharides mimicking the Shigella flexneri 2a O-antigen.
    Said Hassane F; Phalipon A; Tanguy M; Guerreiro C; Bélot F; Frisch B; Mulard LA; Schuber F
    Vaccine; 2009 Aug; 27(39):5419-26. PubMed ID: 19559116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary delivery of insulin by liposomal carriers.
    Huang YY; Wang CH
    J Control Release; 2006 Jun; 113(1):9-14. PubMed ID: 16730838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strategies for cytosolic delivery of liposomal macromolecules.
    Fretz MM; Mastrobattista E; Koning GA; Jiskoot W; Storm G
    Int J Pharm; 2005 Jul; 298(2):305-9. PubMed ID: 15941633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Archaeobacterial ether lipid liposomes as vaccine adjuvants.
    Sprott GD; Patel GB; Krishnan L
    Methods Enzymol; 2003; 373():155-72. PubMed ID: 14714403
    [No Abstract]   [Full Text] [Related]  

  • 16. Needle-free skin patch delivery of a vaccine for a potentially pandemic influenza virus provides protection against lethal challenge in mice.
    Garg S; Hoelscher M; Belser JA; Wang C; Jayashankar L; Guo Z; Durland RH; Katz JM; Sambhara S
    Clin Vaccine Immunol; 2007 Jul; 14(7):926-8. PubMed ID: 17494637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preclinical study of influenza virus A M2 peptide conjugate vaccines in mice, ferrets, and rhesus monkeys.
    Fan J; Liang X; Horton MS; Perry HC; Citron MP; Heidecker GJ; Fu TM; Joyce J; Przysiecki CT; Keller PM; Garsky VM; Ionescu R; Rippeon Y; Shi L; Chastain MA; Condra JH; Davies ME; Liao J; Emini EA; Shiver JW
    Vaccine; 2004 Aug; 22(23-24):2993-3003. PubMed ID: 15297047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lyophilized liposomes as shelf items for the preparation of immunogenic liposome-peptide conjugates.
    Friede M; Van Regenmortel MH; Schuber F
    Anal Biochem; 1993 May; 211(1):117-22. PubMed ID: 8323023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The intracellular and nuclear-targeted delivery of an antiandrogen drug by carrier peptides.
    Hodoniczky J; Sims CG; Best WM; Bentel JM; Wilce JA
    Biopolymers; 2008; 90(5):595-603. PubMed ID: 18351583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peptides and liposomes: from biophysical to immunogenic studies.
    Busquets MA; Alsina MA; Haro I
    Curr Drug Targets; 2003 Nov; 4(8):633-42. PubMed ID: 14577654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.